Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Revised ground rules and

I also agree with you to an extent.

The problem in the past has been, our settlement amount numbers haven't been anything more than nuisance values. As evidenced by the quarterly/yearly filings.

(Maybe to just keep pay checks coming in for the insiders?) I can't argue that point.

PTSC wouldn't have to announce the settlement amount. They could let us know by issuing a fat dividend. That would work...

GL

Share
New Message
Please login to post a reply